Q3 2025 Earnings Call Transcript October 28, 2025 Labcorp Holdings Inc. beats earnings expectations. Reported EPS is $4.18, ...
A merger would significantly change the competitive scene. With Quest and Labcorp being major players, their combination ...
WHOOP Advanced Labs sits inside the WHOOP ecosystem as an optional labs add-on that pairs 65 blood biomarkers with your 24/7 ...
Low Vitamin D could be secretly wrecking your workouts. Discover how this overlooked deficiency impacts energy, muscle ...
Labcorp’s third quarter results met Wall Street’s revenue expectations, but the market responded negatively, reflecting investor concerns about profitability and future growth levers. Management ...
Labcorp announced it will offer the nation's first blood test cleared by the FDA for the initial assessment in Alzheimer's ...
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer the Elecsys pTau181 test, the only blood test cleared by the U.S. Food and Drug ...
Labcorp plans to offer Roche’s recently FDA-cleared blood test to assess early signs of Alzheimer’s disease and other causes ...
Labcorp forecast lower annual revenue growth for its contract research unit on Tuesday, as a prolonged funding crunch continues to weigh on its early-stage drug development clients.
Labcorp on Tuesday raised its annual profit forecast and beat estimates in the third quarter as the laboratory operator ...
BLS revenue reached $799 million, up 8.3%, and adjusted operating income grew to $132 million. The quarter ended with an $8.6 billion backlog, and the BLS book-to-bill was 0.89 for the quarter and ...
Updates Full-Year Guidance Financial results from Operations for third quarter 2025 versus third quarter 2024: Revenue: $3.56 billion versus $3.28 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results